Trial
NCT03575078
ARQ761 + PARP Inhibitor in Refractory Solid Tumors
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Lymphoma
Intervention
ARQ761, Olaparib
Why stopped
Project Never Initiated - no human subjects were enrolled and no data regarding humans was collected or studied
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-25